Enhanced Synergistic Efficacy Against Breast Cancer Cells Promoted by Co-Encapsulation of Piplartine and Paclitaxel in Acetalated Dextran Nanoparticles
Molecular Pharmaceutics · 04.11.2024 · 21 (11) · 5577-5597
DOI: 10.1021/acs.molpharmaceut.4c00548 ↗Kurz gefasst
Fachartikel in der Zeitschrift Molecular Pharmaceutics, online erschienen am 04.10.2024. Verfasst von Carolyne Brustolin Braga und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Organic Chemistry, Institute of Chemistry, University of Campinas, UNICAMP, P.O. Box 6154, 13083-970, Campinas, São Paulo Brazil. Hauptthemen laut MEDLINE: Paclitaxel, Dextrans, Breast Neoplasms, Nanoparticles. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 93 Literaturangaben. Gefördert von: Funda????o de Amparo ?? Pesquisa do Estado de Minas Gerais, Minist??rio da Ci??ncia, Tecnologia e Inova????o, Funda????o de Amparo ?? Pesquisa do Estado de S??o Paulo.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Organic Chemistry, Institute of Chemistry, University of Campinas, UNICAMP, P.O. Box 6154, 13083-970, Campinas, São Paulo Brazil.
- POLYMAT, University of the Basque Country UPV/EHU, Joxe Mari Korta Center, 20018 Donostia-San Sebastián Spain.
- Institute of Biomedical Sciences, Federal University of Alfenas, UNIFAL-MG, 37130-001 Alfenas, Minas Gerais, Brazil.
- R&D Department, ChemistryX, R&D and Consulting Company, 9000 Funchal, Portugal.
- R&D Department, Dendriwave, Research & Development Start-Up Company, 9000 Funchal, Portugal.
ORCID-Profile: Carolyne Brustolin Braga, Gabriel Perli, Catia Ornelas
Förderung
- Funda????o de Amparo ?? Pesquisa do Estado de Minas Gerais
- Minist??rio da Ci??ncia, Tecnologia e Inova????o
- Funda????o de Amparo ?? Pesquisa do Estado de S??o Paulo
- Coordena????o de Aperfei??oamento de Pessoal de N??vel Superior
- Obesity and Comorbidities Research Center
Zitieren
APA
Braga, C. B., Perli, G., Fonseca, R., Grigolo, T. A., Ionta, M., Ornelas, C., & Pilli, R. A. (2024). Enhanced Synergistic Efficacy Against Breast Cancer Cells Promoted by Co-Encapsulation of Piplartine and Paclitaxel in Acetalated Dextran Nanoparticles. Molecular Pharmaceutics, 21(11), 5577-5597. https://doi.org/10.1021/acs.molpharmaceut.4c00548
Vancouver
Braga CB, Perli G, Fonseca R, Grigolo TA, Ionta M, Ornelas C, et al. Enhanced Synergistic Efficacy Against Breast Cancer Cells Promoted by Co-Encapsulation of Piplartine and Paclitaxel in Acetalated Dextran Nanoparticles. Molecular Pharmaceutics. 2024;21(11):5577-5597. doi:10.1021/acs.molpharmaceut.4c00548
BibTeX
@article{Braga2024,
author = {Braga, Carolyne Brustolin and Perli, Gabriel and Fonseca, Rafael and Grigolo, Thiago Augusto and Ionta, Marisa and Ornelas, Catia and Pilli, Ronaldo A},
title = {Enhanced Synergistic Efficacy Against Breast Cancer Cells Promoted by Co-Encapsulation of Piplartine and Paclitaxel in Acetalated Dextran Nanoparticles},
journal = {Molecular Pharmaceutics},
year = {2024},
volume = {21},
number = {11},
pages = {5577--5597},
doi = {10.1021/acs.molpharmaceut.4c00548}
}
EUVIMED